Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Announces Notice of Allowance for Patent Application on REN001
14 oct. 2021 08h00 HE | Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer
11 oct. 2021 08h00 HE | Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Hosting Key Opinion Leader Webinar on McArdle Disease and other Genetic Mitochondrial Myopathies
28 sept. 2021 08h26 HE | Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
09 sept. 2021 09h12 HE | Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Reports Second Quarter 2021 Financial Results
11 août 2021 05h55 HE | Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Announces First Patient Dosed in the STRIDE Study
28 juil. 2021 08h00 HE | Reneo Pharmaceuticals, Inc.
IRVINE, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction
09 juil. 2021 08h00 HE | Reneo Pharmaceuticals, Inc.
SAN DIEGO, July 09, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
07 juil. 2021 08h00 HE | Reneo Pharmaceuticals, Inc.
SAN DIEGO, July 07, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
29 juin 2021 08h00 HE | Reneo Pharmaceuticals, Inc.
SAN DIEGO, June 29, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Reports First Quarter 2021 Financial Results
20 mai 2021 06h00 HE | Reneo Pharmaceuticals, Inc.
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...